A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

Claudine ISAACS; Rebecca SLACK; Edmund GEHAN; Karen BALLEN; Ralph BOCCIA; Ellen AREMAN; Ruthie KRAMER; Daniel F HAYES; Herbert HERSCOWITZ; Marc LIPPMAN

doi:10.1007/s10549-005-4445-y

Back

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

Journal article

Peer reviewed

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

Claudine ISAACS, Rebecca SLACK, Edmund GEHAN, Karen BALLEN, Ralph BOCCIA, Ellen AREMAN, Ruthie KRAMER, Daniel F HAYES, Herbert HERSCOWITZ and Marc LIPPMAN

Breast cancer research and treatment, Vol.93(2), pp.125-134

2005

DOI: https://doi.org/10.1007/s10549-005-4445-y

PMID: 16187232

Abstract

Gynecology. Andrology. Obstetrics

Mammary gland diseases

Biological and medical sciences

Medical sciences

Tumors

Metrics

3 Record Views

2 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.380 GvHD
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients
Creators: Claudine ISAACS - Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, United States
Rebecca SLACK - Division of Biostatistics and Bioinformatics, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, United States
Edmund GEHAN - Division of Biostatistics and Bioinformatics, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, United States
Karen BALLEN - Bone Marrow Transplant Program, University of Massachusetts Memorial Medical Center, Lake Avenue, Worcester, Massachusetts, United States
Ralph BOCCIA - Stem Cell Transplant Program, Holy Cross Hospital, Silver Spring, Maryland, United States
Ellen AREMAN - Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, United States
Ruthie KRAMER - Clinical Research Management Office, Lombardi Comprehensive Cancer Center, Washington, DC, United States
Daniel F HAYES - Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, United States
Herbert HERSCOWITZ - Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States
Marc LIPPMAN - Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, United States
Publication Details: Breast cancer research and treatment, Vol.93(2), pp.125-134
Publisher: Springer; Dordrecht
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 16187232
Record Identifier: 991031577652902976